G1 Therapeutics to Present at August Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Aug. 5, 2015 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that senior management will be presenting at two investor conferences on August 12.

Canaccord Genuity Growth Conference
Location: InterContinental Boston, Boston, MA
Presentation date and time: Wednesday, August 12 at 9:30 a.m. EDT
G1 Presenter: Greg Mossinghoff, Chief Business Officer
For additional information, please visit: http://www.canaccordgenuity.com/en/cm/News-Events/Events/.

Wedbush PacGrow Healthcare Conference
Location: Le Parker Meridien, New York, NY
Presentation date and time: Wednesday, August 12 at 10:20 a.m. EDT
G1 Presenter: Mark Velleca, MD, PhD, Chief Executive Officer
For additional information, please visit: https://www.wedbush.com/services/cmg/equities-division/mgmt-access-events.

About G1 Therapeutics, Inc.

G1 Therapeutics, Inc. is a privately held clinical-stage pharmaceutical company based in Research Triangle Park, NC that focuses on the discovery and development of novel, small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates that address two markets: CDK4/6 antineoplastics and protection of the bone marrow and immune system from damage by chemotherapy (chemoprotection).

Visit www.g1therapeutics.com for more information.

CONTACT: Mark Velleca, MD, PhD G1 Therapeutics 919-213-9838 mvelleca@g1therapeutics.com Media: Laura Bagby 6 Degrees Communications 312-448-8098 lbagby@6degreespr.com

Source: G1 Therapeutics